Sarrabeth Stone

749 total citations
20 papers, 561 citations indexed

About

Sarrabeth Stone is a scholar working on Cell Biology, Molecular Biology and Immunology. According to data from OpenAlex, Sarrabeth Stone has authored 20 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cell Biology, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Sarrabeth Stone's work include Endoplasmic Reticulum Stress and Disease (10 papers), RNA regulation and disease (6 papers) and Autophagy in Disease and Therapy (5 papers). Sarrabeth Stone is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (10 papers), RNA regulation and disease (6 papers) and Autophagy in Disease and Therapy (5 papers). Sarrabeth Stone collaborates with scholars based in United States, New Zealand and Italy. Sarrabeth Stone's co-authors include Wensheng Lin, Shuangchan Wu, Anne Camille La Flamme, Stephanie Jamison, Klaus‐Armin Nave, Yuan Yue, Ryan Kyle, Ruth Schmidt‐Ullrich, Miloš Stanojlović and David O’Sullivan and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and International Journal of Cancer.

In The Last Decade

Sarrabeth Stone

18 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarrabeth Stone United States 15 209 163 143 103 99 20 561
Sharon W. Way United States 8 358 1.7× 154 0.9× 76 0.5× 45 0.4× 49 0.5× 9 627
Friederike Kirsch Germany 12 275 1.3× 149 0.9× 107 0.7× 174 1.7× 39 0.4× 13 683
April Kemper United States 6 188 0.9× 85 0.5× 119 0.8× 124 1.2× 29 0.3× 8 502
Ajit Singh Dhaunchak Canada 12 447 2.1× 115 0.7× 92 0.6× 127 1.2× 46 0.5× 14 794
Sylvaine Guérit Germany 9 343 1.6× 271 1.7× 77 0.5× 173 1.7× 168 1.7× 13 747
María Cristina Ortega Spain 14 252 1.2× 55 0.3× 246 1.7× 254 2.5× 40 0.4× 20 790
Jennifer V. Welser-Alves United States 14 252 1.2× 58 0.4× 91 0.6× 347 3.4× 56 0.6× 17 693
Amber L. Rowse United States 12 287 1.4× 71 0.4× 265 1.9× 288 2.8× 42 0.4× 13 847
Amar Sharma United Kingdom 4 326 1.6× 102 0.6× 43 0.3× 121 1.2× 34 0.3× 5 627
Spyros G.E. Mezitis United States 10 229 1.1× 145 0.9× 172 1.2× 265 2.6× 27 0.3× 24 730

Countries citing papers authored by Sarrabeth Stone

Since Specialization
Citations

This map shows the geographic impact of Sarrabeth Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarrabeth Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarrabeth Stone more than expected).

Fields of papers citing papers by Sarrabeth Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarrabeth Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarrabeth Stone. The network helps show where Sarrabeth Stone may publish in the future.

Co-authorship network of co-authors of Sarrabeth Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Sarrabeth Stone. A scholar is included among the top collaborators of Sarrabeth Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarrabeth Stone. Sarrabeth Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Binder, Michele D., et al.. (2025). Tyro3 deletion is protective in experimental autoimmune encephalomyelitis. Immunology and Cell Biology. 103(9). 857–870.
2.
Stone, Sarrabeth, et al.. (2023). Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system. Communications Biology. 6(1). 555–555. 3 indexed citations
3.
Stone, Sarrabeth, et al.. (2022). Detection of PERK Signaling in the Central Nervous System. Methods in molecular biology. 2378. 233–245.
4.
Stone, Sarrabeth, Shuangchan Wu, Klaus‐Armin Nave, & Wensheng Lin. (2020). The UPR preserves mature oligodendrocyte viability and function in adults by regulating autophagy of PLP. JCI Insight. 5(5). 15 indexed citations
5.
Yue, Yuan, et al.. (2020). NF-κB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE. Journal of Neuroscience. 40(33). 6444–6456. 27 indexed citations
6.
Wu, Shuangchan, Sarrabeth Stone, Klaus‐Armin Nave, & Wensheng Lin. (2020). The Integrated UPR and ERAD in Oligodendrocytes Maintain Myelin Thickness in Adults by Regulating Myelin Protein Translation. Journal of Neuroscience. 40(43). 8214–8232. 24 indexed citations
7.
Wu, Shuangchan, Sarrabeth Stone, Yuan Yue, & Wensheng Lin. (2020). Endoplasmic reticulum associated degradation is required for maintaining endoplasmic reticulum homeostasis and viability of mature Schwann cells in adults. Glia. 69(2). 489–506. 12 indexed citations
8.
Stone, Sarrabeth, et al.. (2019). Neuron-specific PERK inactivation exacerbates neurodegeneration during experimental autoimmune encephalomyelitis. JCI Insight. 4(2). 25 indexed citations
9.
Lin, Wensheng & Sarrabeth Stone. (2019). Unfolded protein response in myelin disorders. Neural Regeneration Research. 15(4). 636–636. 43 indexed citations
10.
Lin, Wensheng, et al.. (2018). Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis. Neural Regeneration Research. 13(9). 1507–1507. 63 indexed citations
12.
Stone, Sarrabeth, et al.. (2017). NF-κB Activation Protects Oligodendrocytes against Inflammation. Journal of Neuroscience. 37(38). 9332–9344. 40 indexed citations
13.
Stone, Sarrabeth & Anne Camille La Flamme. (2016). Type II Activation of Macrophages and Microglia by Immune Complexes Enhances Th17 Biasing in an IL-6-Independent Manner. PLoS ONE. 11(10). e0164454–e0164454. 6 indexed citations
15.
Stone, Sarrabeth, Yeung Ho, Xiting Li, et al.. (2016). Dual role of the integrated stress response in medulloblastoma tumorigenesis. Oncotarget. 7(39). 64124–64135. 17 indexed citations
16.
Stone, Sarrabeth & Wensheng Lin. (2015). The unfolded protein response in multiple sclerosis. Frontiers in Neuroscience. 9. 264–264. 79 indexed citations
17.
White, Madeleine P. J., Gill Webster, David O’Sullivan, Sarrabeth Stone, & Anne Camille La Flamme. (2014). Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis. PLoS ONE. 9(1). e87712–e87712. 28 indexed citations
18.
O’Sullivan, David M., Laura Green, Sarrabeth Stone, et al.. (2014). Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis. PLoS ONE. 9(8). e104430–e104430. 49 indexed citations
19.
Farrand, Kathryn J., et al.. (2014). Enhanced immunosuppression by therapy‐exposed glioblastoma multiforme tumor cells. International Journal of Cancer. 136(11). 2566–2578. 38 indexed citations
20.
Flamme, Anne Camille La, et al.. (2012). Type II-Activated Murine Macrophages Produce IL-4. PLoS ONE. 7(10). e46989–e46989. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026